Next Article in Journal
Combination of Anti-Angiogenics and Checkpoint Inhibitors for Renal Cell Carcinoma: Is the Whole Greater Than the Sum of Its Parts?
Next Article in Special Issue
Glycans as Targets for Drug Delivery in Cancer
Previous Article in Journal
Cancer-on-a-Chip: Models for Studying Metastasis
Previous Article in Special Issue
Expression and Impact of C1GalT1 in Cancer Development and Progression
 
 
Review

Article Versions Notes

Cancers 2022, 14(3), 645; https://doi.org/10.3390/cancers14030645
Action Date Notes Link
article xml file uploaded 27 January 2022 13:24 CET Original file -
article xml uploaded. 27 January 2022 13:24 CET Update -
article pdf uploaded. 27 January 2022 13:24 CET Version of Record https://www.mdpi.com/2072-6694/14/3/645/pdf-vor
article html file updated 27 January 2022 13:25 CET Original file -
article xml file uploaded 4 February 2022 13:40 CET Update -
article xml uploaded. 4 February 2022 13:40 CET Update -
article pdf uploaded. 4 February 2022 13:40 CET Updated version of record https://www.mdpi.com/2072-6694/14/3/645/pdf-vor
article html file updated 4 February 2022 13:41 CET Update -
article xml file uploaded 8 February 2022 05:30 CET Update -
article xml uploaded. 8 February 2022 05:30 CET Update https://www.mdpi.com/2072-6694/14/3/645/xml
article pdf uploaded. 8 February 2022 05:30 CET Updated version of record https://www.mdpi.com/2072-6694/14/3/645/pdf
article html file updated 8 February 2022 05:31 CET Update -
article html file updated 31 July 2022 06:51 CEST Update https://www.mdpi.com/2072-6694/14/3/645/html
Back to TopTop